Remove 2017 Remove Cannabinoids Remove Clinical Trials
article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.

article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear. References Staff, T.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medical Marijuana Offers Hope for Treatment of PTSD

FloridaMarijuana.net

According to a 2017 report published by the National Academies of Sciences , PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. Medical marijuana and cannabinoids can be used to treat a patient’s physical and psychological health, alleviating the symptoms of PTSD.

Treatment 182
article thumbnail

Cann Group (ASX:CAN) and Emyria (ASX:EMD) scrap CBD deal for other opportunities

Cannabis Law Report

Cann Group CEO Peter Crock said of the products: “Satipharm CBD capsules were one of the first medicinal cannabis products available to approved patients in Australia (under the Special Access Scheme) and have been successfully used in a variety of medical conditions since 2017.

CBD 105
article thumbnail

Cannabis Helps, Say Over Half of Parkinson’s Patients Who Use It

The Cannigma

Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.

article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear. References Staff, T.

article thumbnail

CBD Market Report

Project CBD

CBD first appeared on the natural channel’s top 40 list in 2017, ranking 12th, after sales growth of more than 300% from the previous year. million more on CBD products in 2021 compared to 2017 — a 413.4% sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing.

CBD 144